Debora Santoro

454 total citations
26 papers, 311 citations indexed

About

Debora Santoro is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Debora Santoro has authored 26 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Debora Santoro's work include Inhalation and Respiratory Drug Delivery (11 papers), Cystic Fibrosis Research Advances (8 papers) and Asthma and respiratory diseases (7 papers). Debora Santoro is often cited by papers focused on Inhalation and Respiratory Drug Delivery (11 papers), Cystic Fibrosis Research Advances (8 papers) and Asthma and respiratory diseases (7 papers). Debora Santoro collaborates with scholars based in Italy, France and United Kingdom. Debora Santoro's co-authors include Mirco Govoni, Guido Varoli, Dave Singh, Laura Fabbri, Helen Cicirello, David G. Sweet, Zbyněk Straňák, Richard Plavka, R. Chiron and Henryk Mazurek and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and The Journal of Pediatrics.

In The Last Decade

Debora Santoro

23 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debora Santoro Italy 11 238 82 68 53 29 26 311
F. Rathgeb Germany 6 351 1.5× 99 1.2× 64 0.9× 46 0.9× 18 0.6× 9 421
Carolyn Carter United States 5 73 0.3× 75 0.9× 25 0.4× 17 0.3× 49 1.7× 10 324
J S Mann United Kingdom 9 137 0.6× 163 2.0× 20 0.3× 44 0.8× 18 0.6× 16 290
Naveen Kumar Bhatraju India 7 79 0.3× 88 1.1× 7 0.1× 47 0.9× 13 0.4× 17 193
José Pedro Almeida Portugal 10 65 0.3× 102 1.2× 7 0.1× 41 0.8× 12 0.4× 19 216
Benita L. Epstein United States 8 341 1.4× 19 0.2× 208 3.1× 68 1.3× 84 2.9× 10 484
K. Pfister United States 8 113 0.5× 23 0.3× 4 0.1× 23 0.4× 22 0.8× 17 257
H. Sasaki Japan 9 368 1.5× 287 3.5× 15 0.2× 30 0.6× 30 1.0× 17 455
Christine Lejtenyi Canada 5 108 0.5× 30 0.4× 19 0.3× 28 0.5× 57 2.0× 9 342
Liliana Gutiérrez-Carrasquilla Spain 9 58 0.2× 86 1.0× 22 0.3× 12 0.2× 47 1.6× 22 208

Countries citing papers authored by Debora Santoro

Since Specialization
Citations

This map shows the geographic impact of Debora Santoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debora Santoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debora Santoro more than expected).

Fields of papers citing papers by Debora Santoro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debora Santoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debora Santoro. The network helps show where Debora Santoro may publish in the future.

Co-authorship network of co-authors of Debora Santoro

This figure shows the co-authorship network connecting the top 25 collaborators of Debora Santoro. A scholar is included among the top collaborators of Debora Santoro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debora Santoro. Debora Santoro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Govoni, Mirco, et al.. (2023). Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 208(5). 559–569. 5 indexed citations
3.
Dani, Carlo, Gyula Tálosi, György Balla, et al.. (2022). A Randomized, Controlled Trial to Investigate the Efficacy of Nebulized Poractant Alfa in Premature Babies with Respiratory Distress Syndrome. The Journal of Pediatrics. 246. 40–47.e5. 24 indexed citations
4.
Ramanathan, Rangasamy, Manoj Biniwale, Krishnamurthy Sekar, et al.. (2020). Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial. The Journal of Pediatrics. 225. 90–96.e1. 28 indexed citations
5.
Du, Lizhong, Xiaomei Tong, Chao Chen, et al.. (2020). Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates. Frontiers in Pediatrics. 8. 76–76. 4 indexed citations
6.
Singh, Dave, et al.. (2020). Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study. Respiratory Research. 21(1). 246–246. 31 indexed citations
7.
Sweet, David G., M. Turner, Zbyněk Straňák, et al.. (2020). A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. The Journal of Maternal-Fetal & Neonatal Medicine. 35(24). 4739–4742. 5 indexed citations
8.
9.
10.
Sweet, David G., M. Turner, Zbyněk Straňák, et al.. (2017). A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Archives of Disease in Childhood Fetal & Neonatal. 102(6). F497–F503. 51 indexed citations
11.
Singh, Dave, et al.. (2016). A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients. Pulmonary Pharmacology & Therapeutics. 40. 1–6. 33 indexed citations
12.
13.
Singh, Dave, et al.. (2014). The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics. European Respiratory Journal. 44(Suppl 58). P907–P907. 2 indexed citations
14.
Mazurek, Henryk, R. Chiron, А. Г. Чучалин, et al.. (2014). Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis. Pediatric Pulmonology. 49(11). 1076–1089. 21 indexed citations
15.
Papa, Vincenzo, et al.. (2013). Netilmicin/dexamethasone fixed combination in the treatment of conjunctival inflammation. Clinical ophthalmology. 7. 1239–1239. 6 indexed citations
16.
Papa, Vincenzo, et al.. (2012). A new eye gel containing sodium hyaluronate and xanthan gum for the management of post-traumatic corneal abrasions. Clinical ophthalmology. 6. 727–727. 15 indexed citations
17.
18.
Mazurek, Henryk, et al.. (2012). Long-term efficacy and safety of tobramycin 300mg/4mL nebuliser solution in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. 40. 3376. 1 indexed citations
19.
20.
Mazurek, Henryk, R. Chiron, Guido Varoli, et al.. (2011). 111 Comparison of two inhaled tobramycin solutions in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection: results in different age subgroups. Journal of Cystic Fibrosis. 10. S28–S28. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Rathgeb Breakdown of academic impact, for papers by Carolyn Carter Breakdown of academic impact, for papers by J S Mann Breakdown of academic impact, for papers by Naveen Kumar Bhatraju Breakdown of academic impact, for papers by José Pedro Almeida Breakdown of academic impact, for papers by Benita L. Epstein Breakdown of academic impact, for papers by K. Pfister Breakdown of academic impact, for papers by H. Sasaki Breakdown of academic impact, for papers by Christine Lejtenyi Breakdown of academic impact, for papers by Liliana Gutiérrez-Carrasquilla
Rankless by CCL
2026